Schedule 13G ownership disclosure
CTI BIOPHARMA CORP
Security class unavailable · CUSIP: 12648L601
Event date: 2020-03-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000206
- Form type
- SC 13G
- Filer
- CTI BIOPHARMA CORP
- CIK
- CIK 891293
- Filed
- Mar 10, 2020
- Reporting period
- Mar 06, 2020
- Description
- Schedule 13G beneficial ownership